Cargando…
Using Certification to Promote Uptake of Real-World Evidence by Payers
Most randomized controlled trials are unable to generate information about a product’s real-world effectiveness. Therefore, payers use real-world evidence (RWE) generated in observational studies to make decisions regarding formulary inclusion and coverage. While some payers generate their own RWE,...
Autores principales: | Segal, Jodi B., Kallich, Joel D., Oppenheim, Emma R., Garrison, Louis P., Iqbal, Sheikh Usman, Kessler, Marla, Caleb Alexander, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397920/ https://www.ncbi.nlm.nih.gov/pubmed/27003547 http://dx.doi.org/10.18553/jmcp.2016.22.3.191 |
Ejemplares similares
-
Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative
por: Edgar, Babette S, et al.
Publicado: (2021) -
Need for payer-provider partnerships in addressing social determinants of health
por: Kannarkat, Joseph T, et al.
Publicado: (2021) -
Housing Investment Strategies by Healthcare Payers and Systems: Paving the Road Ahead
por: Velasquez, David E., et al.
Publicado: (2023) -
Overview of alopecia areata for managed care and payer stakeholders in the United States
por: King, Brett, et al.
Publicado: (2023) -
Improving patient-reported measures in oncology: a payer call to action
por: Schmidt, Theresa, et al.
Publicado: (2021)